As Australian shares brace for a challenging day with the ASX 200 futures indicating a significant drop, the market sentiment has been further unsettled by both domestic political shifts and international economic disruptions. In this climate, identifying high growth tech stocks requires careful consideration of their resilience to broader market volatility and their potential to capitalize on evolving technological trends amidst uncertain conditions.

Top 10 High Growth Tech Companies In Australia

Name Revenue Growth Earnings Growth Growth Rating Infomedia 7.00% 20.05% ★★★★★☆ Pureprofile 10.51% 37.56% ★★★★★☆ Pro Medicus 19.46% 21.00% ★★★★★☆ Kinatico 13.27% 42.29% ★★★★☆☆ Immutep 104.12% 46.46% ★★★★★☆ Clinuvel Pharmaceuticals 22.04% 26.15% ★★★★★☆ BlinkLab 104.90% 101.40% ★★★★★★ Xero 18.38% 20.72% ★★★★☆☆ PYC Therapeutics 10.34% 24.39% ★★★★★☆ FINEOS Corporation Holdings 9.22% 57.85% ★★★★☆☆

Click here to see the full list of 20 stocks from our ASX High Growth Tech and AI Stocks screener.

Underneath we present a selection of stocks filtered out by our screen.

Data#3

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Data#3 Limited offers IT solutions and services across Australia with a market capitalization of A$1.37 billion.

Operations: The company generates revenue primarily through three segments: Services (A$271.91 million), Software Solutions (A$72.61 million), and Infrastructure Solutions (A$508.14 million).

Data#3, a key participant in Australia's tech sector, has demonstrated robust financial performance with a notable annual revenue growth of 23.2% and earnings growth of 9.8%. This growth trajectory is complemented by its strategic focus on R&D, investing significantly to innovate and stay competitive in the rapidly evolving IT landscape. Recent events such as dividend increases and positive full-year earnings results underscore its strong market position and commitment to shareholder value. With an anticipated high return on equity of 58.7% in three years, Data#3 is well-positioned for future success amidst industry shifts towards more sustainable and advanced tech solutions.

Click to explore a detailed breakdown of our findings in Data#3's health report. Understand Data#3's track record by examining our Past report.ASX:DTL Earnings and Revenue Growth as at Nov 2025

Pro Medicus

Simply Wall St Growth Rating: ★★★★★☆

Overview: Pro Medicus Limited is a healthcare informatics company that develops and supplies imaging software and radiology information system services to hospitals, imaging centers, and healthcare groups across Australia, North America, and Europe with a market cap of A$26 billion.

Operations: Pro Medicus generates revenue primarily from producing integrated software applications for the healthcare industry, amounting to A$212.98 million. The company operates across key regions including Australia, North America, and Europe.

Story Continues

Pro Medicus stands out in the Australian tech landscape, not just for its impressive 19.5% annual revenue growth but also for its strategic R&D investments that fuel innovation in healthcare technology. With earnings surging by 39.2% over the past year, significantly outpacing the industry average of 15%, PME demonstrates a robust competitive edge. The company's future looks promising with an expected earnings growth of 21% per year and a projected return on equity of nearly 51% in three years, highlighting its potential to continue leading in high-stakes markets. Recent engagements like their presentation at Morgan Stanley’s Global Healthcare Conference further underscore their active role in shaping tech-driven healthcare solutions.

Delve into the full analysis health report here for a deeper understanding of Pro Medicus. Gain insights into Pro Medicus' historical performance by reviewing our past performance report.ASX:PME Revenue and Expenses Breakdown as at Nov 2025

Technology One

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Technology One Limited is an enterprise software company that develops, markets, sells, implements, and supports integrated business solutions both in Australia and internationally with a market cap of A$11.24 billion.

Operations: Technology One generates revenue primarily through its software segment, which accounts for A$378.25 million, followed by corporate services at A$90.55 million and consulting services at A$82.87 million.

Technology One, recently added to the S&P/ASX 50 Index, demonstrates robust growth dynamics within Australia's tech sector. With a consistent revenue increase of 12.7% per year and earnings forecast to grow at 15.6% annually, it outpaces the Australian market's average growth rates significantly. The company also stands out for its strategic R&D investments accounting for substantial annual expenditures which fuel innovation and maintain competitive advantage in evolving software markets. The recent appointments of Debra Eckersley and Phil Davis as Non-Executive Directors further strengthen its leadership, positioning Technology One to capitalize on global SaaS trends effectively.

Take a closer look at Technology One's potential here in our health report. Evaluate Technology One's historical performance by accessing our past performance report.ASX:TNE Earnings and Revenue Growth as at Nov 2025

Next Steps

Discover the full array of 20 ASX High Growth Tech and AI Stocks right here. Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks. Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.

Looking For Alternative Opportunities?

Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ASX:DTL ASX:PME and ASX:TNE.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments